Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B

Nucleos(t)ide analogues with high barrier to resistance are regarded as the principal therapeutic option for chronic hepatitis B (CHB). Treatment with entecavir (ETV), tenofovir disoproxil (TDF) and the later released tenofovir alafenamide (TAF) is highly effective at controlling hepatitis B virus (...

Descripción completa

Detalles Bibliográficos
Autores principales: Roade, Luisa, Riveiro-Barciela, Mar, Esteban, Rafael, Buti, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871062/
https://www.ncbi.nlm.nih.gov/pubmed/33614029
http://dx.doi.org/10.1177/2049936120985954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871062/
https://www.ncbi.nlm.nih.gov/pubmed/33614029
http://dx.doi.org/10.1177/2049936120985954

Ejemplares similares